Jolie's Genes, Baffled Public | GenomeWeb

When Angelina Jolie let the world know that she had a preventive mastectomy based on genetic testing for her BRCA1 status and her heightened breast cancer risk, it was her aim to use her celebrity to boost understanding about genetic risk for the disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.